Revision: July 16, 2024, 8:30 a.m.
CHAPTER 196
HB 1349-FN - FINAL VERSION
2024 SESSION
24-2196
02/05
HOUSE BILL 1349-FN
SPONSORS: Rep. H. Howard, Straf. 4; Rep. Vail, Hills. 6; Rep. A. Murray, Hills. 20; Rep. Newell, Ches. 4; Rep. Seibert, Hills. 21; Rep. T. Mannion, Hills. 1
COMMITTEE: Health, Human Services and Elderly Affairs
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill adds generalized anxiety disorder as a qualifying medical condition for the use of therapeutic cannabis.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2196
02/05
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
Be it Enacted by the Senate and House of Representatives in General Court convened:
196:1 New Subparagraph; Use of Cannabis for Therapeutic Purposes; Qualifying Medical Condition; Generalized Anxiety Disorder. Amend RSA 126-X:1, IX(b) by inserting after subparagraph (6) the following new subparagraph:
(7) Generalized anxiety disorder.
196:2 Effective Date. This act shall take effect 60 days after its passage.
Approved: July 12, 2024
Effective Date: September 10, 2024